We await the reaction of the United States of America to the Russian strikes. It was specifically the U.S. proposal - to halt ...

A comprehensive developer guide to implementing secure authentication in modern applications. Covers OAuth 2.0, OIDC, passwordless authentication, passkeys, and enterprise SSO with production-ready ...

LONDON, Jan 7 (Reuters) - GSK (GSK.L), opens new tab will use promising results from two studies of its experimental chronic hepatitis B therapy to support planned regulatory applications, it said on ...

While on the campaign trail, Donald Trump vowed to end the taxation of Social Security benefits. However, this proposal was absent from the president's flagship tax and spending law, the "big, ...

Columbus Mayor Andrew Ginther said he's committed to the Columbus Promise and he took a swipe at the City Council president over the budget issue. Council President Shannon Hardin sat down with The ...

COLUMBUS, Ohio (WCMH) – It appears that the Columbus Promise program could end up being a broken promise. Columbus Promise is a joint initiative for the City of Columbus and Columbus State Community ...

House Speaker Mike Johnson said Thursday he would not guarantee Democrats a vote on extending enhanced tax credits for those with coverage through the Affordable Care Act. Johnson held a news ...

BRIDGEPORT — A long-awaited municipally and privately funded college scholarship program has finally launched in Bridgeport. "This is going to help with one of the metrics that's critically important, ...

GRAND RAPIDS, MI - For two years, Grand Rapids Community College sophomore Alexsandra Aguilar-Delgado has planned to earn her associate’s degree and transfer to nearby Ferris State University. Those ...

Forbes contributors publish independent expert analyses and insights. Marybeth Gasman writes about racism, philanthropy, HBCUs & faculty. During a time when college and university leaders are facing ...

A phase 2 study of response-guided neoadjuvant sacituzumab govitecan and pembrolizumab (SG/P) in patients with early-stage triple-negative breast cancer: Results from the NeoSTAR trial. This is an ...